Budd-Chiari Syndrome Without Biochemical or Clinical Abnormalities and Without Signs of Portal Hypertension
Clinical Scenario
This protocol addresses patients with confirmed Budd-Chiari syndrome who present without biochemical or clinical abnormalities and without signs of portal hypertension — a distinct subgroup in whom the degree of hepatic venous outflow obstruction may be mild, absent at the clinical surface, or offset by collateral outflow routes.
Specific Situation
Asymptomatic patients without biochemical and clinical abnormalities and without signs of portal hypertension may not require interventional treatment, since congestion may be mild, absent, or compensated by other outflow routes. However, the presence of large varices represents a clinically important finding that can alter the management approach in this otherwise quiet presentation.
Treatment Approach (Partial)
When indicated — particularly in the context of large varices — a portosystemic shunt procedure may be considered as a primary prophylactic measure. The specific shunt type, dimensions, and technical specifications are defined in the full protocol. Full regimen details, indications, and technical requirements are available via the structured protocol below.
References
DOI: 10.3390/diagnostics13081458
- As also outlined in Figure 10, asymptomatic patients without biochemical and clinical abnormalities and without signs of portal hypertension may not require interventional treatment since congestion may be mild, absent, or compensated by other outflow routes.
- TIPSs may, therefore, be implanted earlier than usual, e.g., as a primary prophylaxis in patients with large varices.
- It is strongly recommended to create a shunt with a diameter of at least 10 mm to achieve sufficient shunt flow and to relieve hepatic and intestinal congestion.
- Needless to say, only 10 mm PTFE-covered stents should be utilized to optimize flow and long-term patency.
View source ↗